|
Market Closed -
NYSE
01:30:00 02/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.080 USD | -1.82% |
|
-4.42% | -35.33% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
NYSE
LCTX 1.080 $
-1.82%
10L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| LCTX | 1.080USD | -1.82% | 10L $ | |
CBOE
| LCTX | 1.085USD | -1.36% | 25.82T $ | |
|
Tradegate
| BT3 | 0.9370EUR | -1.58% | 9.39T € | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 337.40ILa | +0.42% | 10L ILa | |
|
Deutsche Boerse AG
| BT3 | 0.9120EUR | -0.98% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9120EUR | -0.98% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9520EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.16 | 1.35 | 1.35 |
| Spread/Res. | -6.90% | -20.00% | -20.00% |
| Spread/Supp. | +4.85% | +4.85% | +4.85% |
| Support | 1.03 | 1.03 | 1.03 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
